Understanding the risk factors for cancer can help you make decisions about prevention and screening for early signs of cancer. Here is a look at the five most common cancers in women*, as well as steps you can take to help find these diseases early if needed. 1. Breast cancer As with most cancers, the … Continued
Colon cancer is the fourth most common cancer diagnosed in men and women in the United States. Colon and rectal cancers are often collectively referred to as colorectal cancer. Most colorectal cancers start as a growth on the inner lining of the colon or rectum. These growths — known as polyps — can turn into … Continued
Neuroblastoma is a rare childhood cancer affecting about 800 children each year in the United States. Because of its unusual behavior — tumors in infants often disappear spontaneously without treatment while it can be aggressive in toddlers — studying the disease has been complicated. That may change with a new research tool: a mouse genetically altered … Continued
For almost half of his life, Michael Murray has had to grapple with cancer, including multiple relapses. One of his hardest setbacks was hearing that his cancer had returned just weeks before he was set to start his freshman year at Boston College. With the news, Murray worried that his future would be in jeopardy. … Continued
In their quest for effective targeted therapies to treat triple-negative breast cancer (TNBC) — an aggressive disease that often doesn’t respond to standard chemotherapy — researchers at Dana-Farber and elsewhere have recently focused on the potential of drugs known as BET bromodomain inhibitors. BET inhibitors target a family of proteins including BRD2, BRD3, BRD4, and … Continued
Carly Tobin loves dancing for the fun and freedom it provides. During treatment for a rare pediatric kidney cancer known as Wilms tumor, the pre-teen’s passion also proved a vital source of strength. Diagnosed in early June 2019, Carly — now 11 and cancer-free — underwent surgery, radiation, and chemotherapy at Dana-Farber/Boston Children’s Cancer and … Continued
Scott Sterling spent his entire military career pushing both his mind and body to the limit. A member of the 75th Ranger Regiment, the U.S. Army’s premier large-scale special operations force and a special mission unit within the U.S. Army Special Operations Command, Sterling was trained to endure and overcome any challenge placed in front … Continued
In 2018, Suzy Pope was diagnosed with an aggressive form of cancer known as glioblastoma. Typically forming in the brain or spinal cord, glioblastomas tend to have a fairly grim prognosis. But two and a half years after her diagnosis, Pope continues to thrive and make the most of every day. Her exceptional response to … Continued
Ependymomas are some of the most difficult-to-treat brain tumors. Mariella Filbin, MD, PhD, a neuro-oncologist at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, is driven by a desire to find new therapies for these pediatric brain tumors. At the core of her work is an effort to uncover the events that shape tumor development. Defining how … Continued
Treatment advances for multiple myeloma continue to bring improved outcomes for patients in different stages of their disease. Recent clinical trial reports show progress in treating two myeloma populations — newly diagnosed, transplant eligible patients, and individuals whose disease has progressed following several lines of therapy. In one trial, the phase 2 GRIFFIN study showed … Continued
The ongoing COVID-19 pandemic has resulted in a uniquely uncertain and stressful way of life for us all. Not knowing what will happen next — in addition to fear for our own health, that of our loved ones, and the disruption to our lives — can lead to distress and depression. This can be particularly … Continued
Liver cancer that develops in people with obesity and Type 2 diabetes is dependent on elevated amounts of a protein that might be targeted for treatment by two existing drugs, say Dana-Farber scientists. The research reported in Cancer Research by Pere Puigserver, PhD, and colleagues pertains specifically to liver cancer in individuals who are obese … Continued
Immunocompromised individuals are potentially at a higher risk for severe illness from the coronavirus, or COVID-19, according to the Centers for Disease Control and Prevention (CDC). We’re here to help — here is some general information about what it means to be immunocompromised, and how you can protect yourself. This information is specific to people … Continued
By Mae Reilly, MS, RD, LDN, senior clinical nutritionist at Dana-Farber Cancer Institute “Does sugar feed cancer?” is one of the most frequently asked questions we receive as oncology dietitians. Researchers continue to investigate the relationship between sugar intake and cancer; meanwhile, there are steps you can take to avoid any potential harm that sugar … Continued
Lymph nodes are key components of the body’s immune system. These small, bean-shaped capsules are located throughout the body and are responsible for filtering lymph fluid and removing harmful substances. They also contain immune cells, which help fight infections by attacking germs and bacteria carried through this fluid. Typically, lymph nodes are soft and undetectable. However, … Continued
In a small percentage of women, a painful breast lump turns out to be cancer.
Lung cancer is divided into two general categories based on its appearance under the microscope: small cell and non-small cell. Non-small cell is the more common type and currently accounts for about 87 percent of lung cancers. Doctors make a distinction between the two types of lung cancers because treatment approaches differ for each. There have been many … Continued
Due to COVID-19, Ava Girolimetti doesn’t know if she will be starting middle school this September in a classroom, on a computer screen, or a combination of both. But thanks to CAR T-cell therapy for acute lymphoblastic leukemia (ALL), she plans to be there cancer-free. The rising sixth grader can make this claim as one … Continued
There are many different treatment options available for breast cancer, including a type of surgery called a lumpectomy. While surgery can be anxiety-inducing, rest assured that lumpectomies are extremely safe and usually take no more than an hour. Here, Anna Weiss, MD, a breast surgeon in the Breast Oncology Program at the Susan F. Smith Center for Women’s Cancers at Dana-Farber/Brigham … Continued
While the vast majority of people diagnosed with cancer do not develop a different malignancy later in life, it’s important for survivors to be aware of factors that can put them at risk. People who have had cancer may in some cases have a higher than average risk of developing a new cancer — that … Continued
